These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 23339387)
1. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis. Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study. Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064 [TBL] [Abstract][Full Text] [Related]
3. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis. Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study. Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949 [TBL] [Abstract][Full Text] [Related]
5. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075 [TBL] [Abstract][Full Text] [Related]
6. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients. Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860 [TBL] [Abstract][Full Text] [Related]
7. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Kikuch K; Saniabadi AR Digestion; 2004; 70(1):36-44. PubMed ID: 15297776 [TBL] [Abstract][Full Text] [Related]
8. Shorter Relapse-Free Period after Leukocyte Removal Therapy in Younger than Older Patients with Ulcerative Colitis. Yamasaki S; Sakata Y; Yoshida H; Shirai S; Tanaka Y; Nakano R; Yukimoto T; Tsuruoka N; Shimoda R; Fukuda M; Miyazono M; Ikeda Y; Iwakiri R; Anzai K; Fujimoto K Digestion; 2019; 100(4):247-253. PubMed ID: 30540999 [TBL] [Abstract][Full Text] [Related]
9. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis. Yamamoto T; Umegae S; Matsumoto K J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094 [TBL] [Abstract][Full Text] [Related]
10. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients. Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290 [TBL] [Abstract][Full Text] [Related]
11. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants. Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T Digestion; 2011; 84(1):3-9. PubMed ID: 21311190 [TBL] [Abstract][Full Text] [Related]
12. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314 [TBL] [Abstract][Full Text] [Related]
13. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up. Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440 [TBL] [Abstract][Full Text] [Related]
14. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications. Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Kanke K; Nakano M; Hiraishi H; Terano A Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427 [TBL] [Abstract][Full Text] [Related]
16. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis. Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839 [TBL] [Abstract][Full Text] [Related]
19. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Hanai H; Watanabe F; Takeuchi K; Iida T; Yamada M; Iwaoka Y; Saniabadi A; Matsushita I; Sato Y; Tozawa K; Arai H; Furuta T; Sugimoto K; Bjarnason I Clin Gastroenterol Hepatol; 2003 Jan; 1(1):28-35. PubMed ID: 15017514 [TBL] [Abstract][Full Text] [Related]
20. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]